Rytary regulatory update

FDA extended the PDUFA date by 3 months for an NDA from Impax for Rytary extended-release carbidopa/levodopa to treat idiopathic Parkinson's disease (PD). The new date is Jan. 21, 2013; it was Oct. 21...